UBS Group AG Increases Stake in Exponent, Inc. (EXPO)
UBS Group AG raised its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 0.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 36,673 shares of the business services provider’s stock after buying an additional 98 shares during the period. UBS Group AG owned 0.14% of Exponent worth $2,184,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in the stock. Thrivent Financial for Lutherans increased its position in shares of Exponent by 5.1% in the fourth quarter. Thrivent Financial for Lutherans now owns 13,870 shares of the business services provider’s stock worth $836,000 after buying an additional 670 shares in the last quarter. Nationwide Fund Advisors increased its position in shares of Exponent by 4.8% in the first quarter. Nationwide Fund Advisors now owns 159,560 shares of the business services provider’s stock worth $9,502,000 after buying an additional 7,296 shares in the last quarter. Bank of Montreal Can increased its position in shares of Exponent by 21.8% in the first quarter. Bank of Montreal Can now owns 3,209 shares of the business services provider’s stock worth $192,000 after buying an additional 575 shares in the last quarter. Oxford Asset Management purchased a new position in shares of Exponent during the first quarter worth $1,174,000. Finally, Louisiana State Employees Retirement System increased its position in shares of Exponent by 1.0% in the first quarter. Louisiana State Employees Retirement System now owns 10,400 shares of the business services provider’s stock worth $619,000 after buying an additional 100 shares in the last quarter. 90.49% of the stock is owned by hedge funds and other institutional investors.
Exponent, Inc. (NASDAQ EXPO) traded up 1.52% during midday trading on Friday, reaching $66.65. 126,592 shares of the company’s stock were exchanged. The company has a market cap of $1.76 billion, a price-to-earnings ratio of 34.55 and a beta of 0.62. The firm has a 50-day moving average price of $60.42 and a 200 day moving average price of $59.43. Exponent, Inc. has a 12-month low of $48.42 and a 12-month high of $68.30.
Exponent (NASDAQ:EXPO) last issued its quarterly earnings data on Tuesday, July 18th. The business services provider reported $0.51 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.41 by $0.10. Exponent had a net margin of 15.94% and a return on equity of 16.52%. The business had revenue of $84.10 million during the quarter, compared to analyst estimates of $79.30 million. During the same period in the prior year, the business earned $0.38 EPS. The company’s revenue for the quarter was up 14.7% on a year-over-year basis. On average, analysts expect that Exponent, Inc. will post $1.97 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 22nd. Shareholders of record on Friday, September 1st will be issued a $0.21 dividend. The ex-dividend date is Wednesday, August 30th. This represents a $0.84 annualized dividend and a yield of 1.26%. Exponent’s dividend payout ratio (DPR) is presently 43.52%.
ILLEGAL ACTIVITY WARNING: This report was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/08/04/exponent-inc-expo-stake-increased-by-ubs-group-ag-updated-updated-updated.html.
A number of brokerages recently weighed in on EXPO. Zacks Investment Research raised shares of Exponent from a “hold” rating to a “buy” rating and set a $74.00 target price for the company in a research note on Thursday, July 20th. Cantor Fitzgerald reissued a “buy” rating and set a $75.00 target price (up previously from $69.00) on shares of Exponent in a research note on Wednesday, July 19th. ValuEngine raised shares of Exponent from a “sell” rating to a “hold” rating in a research note on Thursday, July 20th. Finally, BidaskClub raised shares of Exponent from a “strong sell” rating to a “sell” rating in a research note on Wednesday, July 5th.
In other Exponent news, CEO Paul R. Johnston sold 5,000 shares of the company’s stock in a transaction on Tuesday, August 1st. The shares were sold at an average price of $65.94, for a total value of $329,700.00. Following the completion of the transaction, the chief executive officer now directly owns 66,335 shares in the company, valued at approximately $4,374,129.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider John Pye sold 3,600 shares of the company’s stock in a transaction on Monday, July 24th. The stock was sold at an average price of $65.08, for a total transaction of $234,288.00. Following the completion of the transaction, the insider now owns 14,767 shares of the company’s stock, valued at $961,036.36. The disclosure for this sale can be found here. Insiders sold a total of 9,855 shares of company stock valued at $646,027 over the last 90 days. Company insiders own 2.80% of the company’s stock.
Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.
Receive News & Stock Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related stocks with our FREE daily email newsletter.